CAMK2B and brain ischemia: In addition to CaMKIIβ controlling cell surface GABAB receptor expression under normal physiological conditions, it rapidly downregulates the receptors upon sustained activation of glutamate receptors [29–32], a pathological condition that occurs in cerebral ischemia and leads to excitotoxic cell death [42, 43].